(Q39649952)

English

Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.

scientific article published on 14 February 2012

In more languages
default for all languages
No label defined

No description defined

Statements

Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit